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SHARING INTERNATIONAL REGIMEN AND OTHER 
INTERNATIONAL INSTRUMENTS: THE WORLD TRADE 
ORGANIZATION AND THE INTERNATIONAL UNION  
FOR THE PROTECTION OF NEW VARIETIES OF PLANTS
by Jorge Cabrera Medaglia*
* Professor, Environmental Law, University of Costa Rica, Legal Adviser, 
National Biodiversity Institute (INBio), Lead Council Biodiversity Law. Inter-
national Center for Sustainable Development Law, Montreal. Former Co-Chair, 
ABS Expert Panel of the CBD. This article is based on the author’s previous 
research, Jorge Cabrera Medaglia, The relationship between the International 
Regimen, the World Trade Organization, the World Intellectual Property Orga-
nization and the Convention for the Protection of New Varieties of Plants, pre-
pared for the CBD Secretariat in April, 2009.
INTRODUCTION
This article examines the relationship between the Interna-tional Regimen (“IR”) and the World Trade Organization (“WTO”) and International Convention for the Protec-
tion of New Varieties of Plants (“UPOV”). The article high-
lights the potential relationship between the intellectual property 
rights system and the negotiations on an international regime for 
access and benefit-sharing within the context of the Convention 
on Biological Diversity (“CBD”), and identifies some questions 
requiring further scrutiny. The WTO, World Intellectual Prop-
erty Organization (“WIPO”), and UPOV each have provisions 
related to Access to Genetic Resources and Benefit Sharing 
(“ABS”) and Intellectual Property Rights (“IPR”). Meanwhile, 
there are ongoing negotiations on an international regime gov-
erning access to and the equitable sharing of benefits from 
genetic resources derived from biodiversity under the CBD.
The first section provides a general introduction, while the 
second gives an overview and a factual description of the other 
instruments, as well as their provisions related to ABS and the 
relationships between the IR and the ABS provisions or devel-
opments identified. The third section seeks to address the dif-
ferent scenarios and options to achieve mutual supportiveness 
between the IR and the instruments. Finally, some general con-
clusions are presented.
THE CONVENTION ON BIOLOGICAL DIVERSITY AND ITS 
RELEVANT ABS PROVISIONS
The Convention on Biological Diversity recognizes the sov-
ereign rights of States over their natural resources in areas under 
their jurisdiction.1 The Objectives of the Convention on Biologi-
cal Diversity are:
1. The conservation of biological diversity;
2. The sustainable use of the components of biological 
diversity; and
3. The fair and equitable sharing of the benefits arising 
out of the utilization of genetic resources2
According to the Convention, States have the authority to 
determine access to genetic resources in areas within their juris-
diction. Parties also have the obligation to take appropriate mea-
sures with the aim of sharing in a fair and equitable way the 
benefits arising from the utilization of genetic resources.3 Two 
further principles established under article 15 of the CBD are 
that “access [to genetic resources], where granted, shall be on 
mutually agreed terms” and “shall be subject to prior informed 
consent of the Contracting Party providing such resources, 
unless otherwise determined by that Party.”4 This provides the 
basic legal framework under the Convention for access and ben-
efit sharing arising from the utilization of genetic resources.
Furthermore, the protection of traditional knowledge, inno-
vations, and practices of indigenous and local communities plays 
an important role. Traditional knowledge often provides a lead 
to genetic resources with beneficial properties and can thus form 
the basis for ABS mechanisms or entitlements. To this effect, 
Article 8(j) states that:
each contracting Party shall, as far as possible and as 
appropriate, subject to national legislation, respect, pre-
serve and maintain knowledge, innovations and prac-
tices of indigenous and local communities embodying 
traditional lifestyles relevant for the conservation and 
sustainable use of biological diversity and promote 
their wider application with the approval and involve-
ment of the holders of such knowledge, innovations 
and practices and encourage the equitable sharing of 
the benefits arising from the utilization of such knowl-
edge innovations and practices.5
ABS activities should be based on the Bonn Guidelines on 
Access to Genetic Resources and Fair and Equitable Sharing of 
the Benefits Arising out of their Utilization.6
CURRENT STATUS AND PERSPECTIVES OF THE IR 
NEGOTIATIONS7
The World Summit on Sustainable Development in Johan-
nesburg in 2002 agreed to the establishment of an international 
regime to effectively promote and safeguard fair and equitable 
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benefit-sharing. On December 20, 2002, Resolution 57-260 of 
the United Nations General Assembly invited the Conference of 
the Parties to take the necessary measures regarding the commit-
ment established at the Summit to negotiate this regime.8 Taken 
together with the Convention’s decision this represents a com-
mitment to create an international regime.
Paragraph 42(n) of the same Johannesburg Plan of Action 
provided a related commitment to
Promote the wide implementation of and continued 
work on the Bonn Guidelines on Access to Genetic 
Resources and Fair and Equitable Sharing of Benefits 
arising out of their Utilization of the Convention, as an 
input to assist Parties to the Convention when devel-
oping and drafting legislative, administrative or policy 
measures on access and benefit-sharing, and contracts 
and other arrangements under mutually agreed terms 
for access and benefit-sharing.9
Decision VII/19 of the Conference of the Parties of the 
CBD is potentially one of the most comprehensive and detailed 
of all of the decisions having to do with the issue of access to 
genetic resources. This decision calls for the Working Group on 
ABS to meet again
. . . with the collaboration of the Ad Hoc Open-ended 
Inter-Sessional Working Group on Article 8 (j) and 
Related Provisions, ensuring the participation of 
indigenous and local communities, non-governmental 
organisations, industry and scientific and academic 
institutions, as well as intergovernmental organisations, 
to elaborate and negotiate an International Regime on 
access to genetic resources and benefit-sharing with 
the aim of adopting an instrument/instruments to effec-
tively implement the provisions in Article 15 and Arti-
cle 8 (J) of the Convention and the three objectives of 
the Convention.10
The group has operated in accordance with the terms of ref-
erence contained in the Annex to Decision VII/19. The Confer-
ence of the Parties also decided on the terms of reference for 
such a negotiation, including the process, nature, scope, and ele-
ments for consideration in the elaboration of the regime. The 
terms of reference are contained in the annex to Decision VII/19 
D.11 As set out in the Terms of reference of the Working Group 
on ABS, the IR could be composed of one or more instruments 
within a set of principles, norms, rules, and decision-making 
procedures, legally-binding and/or non-binding.
According to these same Terms of reference, the scope of 
the IR is to include:
• Access to genetic resources and promotion and safeguard-
ing of fair and equitable sharing of the benefits arising out of 
the utilization of genetic resources in accordance with rel-
evant provisions of the Convention on Biological Diversity;
• Traditional knowledge, innovations and practices in accor-
dance with Article 8(j).12
At the eighth meeting of the Conference of the Parties 
(“COP”) in Curitiba, Brazil, the Working Group was requested 
to complete its work as soon as possible and no later than 2010.13 
In addition to COP 8, two meetings of the Working Group on 
ABS, as the negotiating body of the international regime, were 
held prior to the ninth meeting of the Conference of the Parties. 
The Working Group held its fifth meeting in Montreal, Canada, 
from October 8-12, 2007,14 and its sixth meeting in Geneva, 
Switzerland, from January 21-25, 2008.15 At its ninth meeting 
in Bonn, in May 2008, the COP extended the mandate of the 
Working Group on Access and Benefit-sharing, and instructed it 
to finalize the negotiation of the international regime before its 
tenth meeting, in 2010.16 The COP adopted a detailed calendar 
of meetings to achieve this objective and decided that the Ad 
Hoc Open-ended Working Group on Access and Benefit-sharing 
should meet three times prior to the tenth meeting of the Con-
ference of the Parties. In addition, the COP decided to establish 
three distinct groups of technical and legal experts to address 
key substantive issues at the core of the negotiation process.
The seventh meeting of the Working Group, held in Paris, 
France, in April 2009, focused on the objective and scope of the 
International Regime, as well as the components of the Interna-
tional Regime related to compliance, benefit-sharing, and access.
At its eighth meeting (November 9-15, 2009, in Montreal, 
Canada), the Working Group addressed operative text on all 
components of the regime, and discussed its legal nature. The 
meeting adopted the Montreal Annex, 17 consisting of a single, 
consolidated draft of the international regime, and a second 
annex on proposals for operational texts left in abeyance for 
consideration at its ninth meeting, referred to as ABS 9. The 
Working Group also established an intersessional process lead-
ing up to ABS 9, including: a Friends of the Co-Chairs group; 
a Co-Chairs’ Inter-regional Informal Consultation; and a series 
of regional consultations. Given the fundamental disagree-
ments, only a heavily bracketed structure exists as a basis for the 
negotiations on the regime.18 The document has four sections, 
covering the objective, scope, main components, and nature of 
the regimen. The content of each section, however, identifies 
various options or is heavily bracketed. The text regarding the 
main components includes: benefit sharing, access, compliance, 
capacity building, and traditional knowledge and also reflects 
the wide divergence of positions among countries.
The inter-regional consultation (March 16-18, 2010, in Cali, 
Colombia) was held in order to identify concrete solutions to 
facilitate and accelerate ABS 9 negotiations. As a result, the Co-
Chairs prepared a draft protocol and a draft COP decision was 
circulated prior to ABS 9. At the ninth meeting of the Work-
ing Group in Cali, Colombia, from March 22-28, 2010, a draft 
protocol was tabled by the Co-Chairs and accepted by Parties 
as a basis for further negotiations. However, since it was not 
possible to finalize the text at this session, the Working Group 
decided to suspend the meeting at the end of the seven days and 
to resume the ninth meeting of the Working Group in order for it 
to complete its mandate.19 The text of the Protocol (still subject 
to negotiation) became Annex I of the Report.20 Subsequently 
the CBD Secretary notified21 formally to the Parties and other 
stakeholders the text of the Protocol pursuant to article 28 of the 
CBD.22 A roadmap to Nagoya was also agreed upon, including 
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the reassumed session of the ABS/WG to be held in Montreal in 
July 10-16, 2010. Out of the Cali meeting came a draft protocol 
text upon which negotiations can move forward towards creat-
ing the international regime. But the text is still open for modifi-
cation and additions.
As a result of the ninth meeting, the Draft Protocol on 
ABS23 addresses the following issues of interest for this article: 
disclosure requirements in IPR applications; the certificate of 
compliance and technology transfer.24
OVERVIEW AND FACTUAL DESCRIPTION OF THE 
RELEVANT ABS PROVISIONS AND DEVELOPMENTS  
AT THE WTO AND UPOV25
FACTUAL OVERVIEW OF RELEVANT PROVISIONS/
DEVELOPMENTS/PROCESSES AT THE WTO AGREEMENT 
ON TRADE-RELATED ASPECTS OF INTELLECTUAL 
PROPERTY RIGHTS
Since the entry into force of the TRIPS Agreement, there 
have been calls, mainly by developing countries, to explore the 
relationship between the CBD and intellectual property rights 
(“IPRs”). In parallel, CBD COP decisions26 have stressed the 
need to gather information on the impact of IPRs on achiev-
ing the objectives of the CBD, and to explore the relationship 
between the Convention and the TRIPS Agreement.27
As early as COP 3,28 the CBD Secretariat was requested to 
cooperate with the WTO through the Committee on Trade and 
Environment (“CTE”) to explore the extent to which there may 
be linkages between CBD Article 15 on ABS and relevant provi-
sions of the TRIPS Agreement. In the WTO context, the TRIPS 
Council has included the relationship between TRIPS and the 
CBD on numerous occasions in its discussions.29 Some of the 
debates about the links between the CBD and WTO took place 
in the context of the TRIPS review of Article 27.3(b), which was 
started by the TRIPS Council during 1999, four years after the 
entry into force of the Agreement.
There have also been similar discussions regarding the 
TRIPS Agreement under the CTE, including protection of Tra-
ditional Knowledge; the transfer of environmentally sound tech-
nology; ethical concerns associated with the patenting of living 
organisms; and compatibility between TRIPS and the CBD.30
The TRIPS Council has also discussed what the implica-
tions of IPRs are for access to and transfer of technology. One 
view has been that IPRs in respect of genetic resources could 
impede access to and raise the cost of technology in this area, by 
virtue of the exclusive rights given to rights-holders to prevent 
others from using the protected technology. In response, it has 
been argued that full implementation of the TRIPS Agreement 
in developing countries would stimulate investment in those 
countries and that, therefore, facilitated technology transfer 
forms part or the basis of benefit sharing as envisaged under the 
CBD.31 Technology transfer is also a relevant issue addressed 
by the CBD. Article 16 of the CBD on access to and transfer 
of technology contains numerous references to IPRs. CBD COP 
7 adopted a program of work on technology transfer and tech-
nological and scientific cooperation, which required the CBD 
Secretariat to prepare, in collaboration with UNCTAD, WIPO, 
and other relevant international organizations, technical stud-
ies32 to explore and analyze the role of IPRs in technology trans-
fer, in the context of the CBD, and identify potential options to 
increase synergy and overcome barriers to technology transfer 
and cooperation.33
Later, in 2001, the Doha Declaration, which launched the 
current round of trade negotiations, specifically instructed the 
TRIPS Council to examine the relationship between the TRIPS 
Agreement and the Convention on Biological Diversity, the pro-
tection of traditional knowledge and folklore, and other new and 
relevant developments pointed out by the Members.34 In particu-
lar, the TRIPS Council shall take this into account in conducting 
the examination provided for in paragraph 3(b) of article 27; the 
examination of the application of the TRIPS Agreement pro-
vided for in paragraph 1 of article 71; and in its work in compli-
ance with paragraph 12 of the Declaration. In carrying out this 
work, the TRIPS Council shall be governed by the objectives 
and principles stated in articles 7 and 8 of the TRIPS Agreement 
and shall fully consider the dimension of development.
Though this debate was originally wide-ranging,35 it now 
focuses on how the TRIPS agreement relates to the CBD and 
particularly whether the agreement should be amended to require 
disclosure in IPR applications, which has been discussed in the 
WTO based on the mandate established in Doha, or whether 
alternative approaches, including contractual based systems or 
databases of genetic resources and traditional knowledge, could 
be more effective in ensuring mutual supportiveness between 
the TRIPS and the CBD.
One of the first measures suggested in order to achieve 
mutual supportiveness between the CBD and intellectual prop-
erty systems (in particular, the WTO TRIPS) was the disclo-
sure of the origin of genetic resources or associated traditional 
knowledge in intellectual property rights applications, particu-
larly in patents. It has been suggested by developing countries 
mostly that the TRIPS Agreement should be amended so as to 
require that patent applicants disclose, as a condition to patent-
ability one or more of the following: the source and origin of any 
genetic material used in a claimed invention; and/or any related 
traditional knowledge used in the invention; evidence of prior 
informed consent from the competent authority in the country of 
origin of the genetic material; and evidence of fair and equitable 
benefit sharing. Proponents of disclosure requirements argue 
that this stipulation would help to support compliance with the 
CBD provisions on access to genetic resources and benefit-shar-
ing.36 In response, it has been expressed that such a modifica-
tion is not necessary to implement the CBD requirements as they 
should be implemented through corresponding contracts at the 
national level, and that the TRIPS Agreement is not the appro-
priate instrument to regulate ABS.
The Declaration adopted at the Ministerial Summit in 2005 
in Hong Kong provides (in paragraph 44) that note be taken of 
the work carried out by the TRIPS Council, in accordance with 
paragraph 19 of the Doha Declaration, and agrees that work will 
continue based on this paragraph and on the progress made to 
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date.37 In addition, in accordance with paragraph 39 concern-
ing implementation, it was decided to address the relationship 
between the TRIPS Agreement and the CBD through a consulta-
tion process on different aspects of implementation.38 This con-
sultation is being carried out with the intervention of the Deputy 
Director General of the WTO.
In May 2006, six countries, including India, Brazil, and 
Peru, submitted a proposal to the TRIPS Council suggesting 
concrete changes to the TRIPS Agreement in order to support 
disclosure of origin. The Communication39 aims to incorporate 
a new article 29 bis into the TRIPS Agreement. It proposes an 
amendment to the TRIPS Agreement to incorporate require-
ments for disclosure of the origin of genetic resources40 and 
associated traditional knowledge 
in patent applications along with 
evidence of prior informed con-
sent and benefit-sharing.41
At the Mini-Ministerial 
Conference held in July 2008,42 
not much changed. A deter-
mination regarding the pro-
posed amendment to the TRIPS 
Agreement to incorporate the 
disclosure of origin remains to 
be made at the WTO. A Draft 
Modality text on IP was pre-
sented including negotiations on 
disclosure.43 The Draft called44 
for text based negotiations on the 
IP issues, including disclosure. 
This Draft Modalities proposal 
for negotiating the IP issues at 
the Ministerial level has gath-
ered the support of the majority 
of developing country Members 
and some developed countries 
as well. A large coalition of 
more than a hundred develop-
ing and developed countries led 
by Brazil, the EU, India, and Switzerland, were pushing for the 
three TRIPS issues to be moved forward as a single undertaking 
in the Round, but the proposal was strongly rebuffed by some 
country Members who contended that the intellectual property 
issues should not be discussed in tandem with the Doha negotia-
tions on liberalizing trade in agricultural and industrial goods.
The issue of disclosure was also raised at the several TRIPS 
Council Meetings after the July Mini-Ministerial45 in 2009 and 
2010, with similar results. In essence, countries largely reiter-
ated known positions on the relationship between the TRIPS 
Agreement and the Convention on Biological Diversity. Mean-
while, informal consultations on how to move the issue forward 
are ongoing. However, like all issues discussed at the July Mini-
Ministerial Conference, the future of the TRIPS issues depend 
upon the future of the negotiations.
Relationship between the IR and WTO
As presented in the previous section, discussions on the 
relationship between the CBD and the WTO provisions have 
addressed a range of issues and several proposals have been 
presented. However, the current debate has focused on the dis-
closure of origin in patent applications or whether alternative 
approaches including contractual based systems or databases 
of genetic resources and traditional knowledge could be more 
effective in ensuring mutual supportiveness between TRIPS and 
the CBD. In addition, technology transfer (“TT”) is a relevant 
issue connecting the IR and the WTO.
There are other issues connecting the WTO and the potential 
IR, but they can be briefly mentioned here, including: the appli-
cability of the WTO investment 
provisions to the ABS activities; 
and the relationships between 
the Principle of Non Discrimi-
nation (the Most Favored Nation 
and National Treatment Prin-
ciples); and ABS legislation and 
practices, among others.46
•  Disclosure of origin
The Annex of Decision 
IX/12 has identified five compo-
nents for the IR. These include: 
access; fair and equitable ben-
efit sharing; compliance mea-
sures; traditional knowledge; 
and capacity building. Under the 
Compliance component one of 
the measures for “further con-
sideration”47 is the disclosure 
requirements. Decision VIII/4/D 
is more clear about disclosure in 
the context of the CBD IR nego-
tiations.48 The Draft Protocol49 
provides
In implementing Article 12, 
paragraph 1, Parties shall take measures, as appropriate, 
to monitor the utilization of genetic resources, includ-
ing from derivatives produced through expression, rep-
lication and characterization, having regard to the list 
of typical uses of genetic resources provided in Annex 
II of the present Protocol. Such measures include: (a) 
The identification and establishment of check points 
and disclosure requirements including at
(iv) Intellectual property examination offices50
• Certificate of Origin/Source/Legal Provenance/Compliance.51
One element ABS negotiations have focused on in order to 
respond to the call for user country measures, and to contribute 
to solving problems related to the monitoring and traceability of 
genetic resources, is the development of some form of certificate 
of origin/source/legal provenance—more recently called a “cer-
tificate of compliance.” The idea of the certificate is to prevent 
Due to the nature 
of a legally binding 
instrument of the [Access 
and Benefits Sharing] 
Protocol, the countries 
should develop—in their 
national legislation—
disclosure of origin 
requirements to comply 
with the international 
obligations.
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or minimize problems generated by the existence of two differ-
ent jurisdictions for ABS arrangements—that of the place where 
the material is collected and that of the place where research 
and development activities are carried out. The existence of an 
internationally recognized document would make it possible to 
check the legality of access at the place where the activity (pat-
ent, product approval, etc.) generates value, and to discover the 
subsequent use of the resources and the origin of the correspond-
ing benefit-sharing. At the same time, this supposedly52 would 
favor the creation of simpler access systems in provider coun-
tries, because existing control mechanisms would be applied, 
via the certificate, in the later stages of research and develop-
ment, thus helping to make the regulations on access to genetic 
resources more flexible. In this way, monitoring and regulation 
would be less strict during the access phase and stricter during 
the research and development phase, where control or check 
points would be established. This implies that the documen-
tation would need to pass through the various buyers, but the 
monitoring points would be reserved only for certain milestones 
in the research and development process, such as those related to 
product approval, IPR applications, publications, the presenta-
tion of funding proposals, etc.
Many aspects still need to be clarified before this system 
can become operational, including:
1. The designation of national authorities to issue certifi-
cates that are mutually recognized.
2. The identification of conditions for verification of and 
compliance with the certificates, that is, the determina-
tion of which materials they would apply to, for what 
purposes, and at what moment or stage they would be 
verified.
3. Exemptions.
4. Provisions for cases in which it is not possible to 
identify the origin of the genetic resources, including 
benefit-sharing.
5. Differential treatment of different sectors.
6. Dispute settlement mechanisms.
7. The creation of an international certificate register.
8. How countries that are not parties to the IR will be 
handled.
9. Provisions related to the resources contained in ex-situ 
collections prior to the Convention. 53
Other aspects of interest could include:
1. What the certificate corresponds to: species, genes, spe-
cific biological samples, etc.
2. Transaction costs of the certificate.
3. Different types of certificates: origin, legal provenance, 
source.
4. Characteristics of the system: simplicity, flexibility, 
avoidance of complex procedures.
5. Considerations regarding the product supply chain, etc.
6. Ability to comply with the objectives of the CBD, 
especially conservation.
7. Economic impacts and implications of the certificate 
for different actors (botanical gardens, etc.).
8. Content of the certificate.
9. Sanctions for non-compliance.
10. Lack of legislation on access.
11. Procedures for control and use of the Clearing House.
12. How to ensure that additional barriers are not created 
for the non-commercial exchange of resources.
13. Compatibility with international trade regimes,54 etc.
Depending on the certificate’s final design, some rules of 
the trade system might apply to it, especially those related to 
technical barriers to trade. For instance, if the certificate is going 
to be checked at customs and if the legal consequences of not 
producing a certificate are the prohibition of the entry of the 
genetic resources—for which the certificate should have been 
issued—into a country. However, the potential implications of 
such rules on the certificate need to be better understood.
With regard to the compliance component of the IR, the 
Annex of Decision IX/12 identified as an area for “further elabo-
ration” the “Development of tools to monitor compliance: . . . b) 
(an) internationally recognized certificate issued by a domestic 
competent authority.”55 The Draft Protocol provides that the:
disclosure requirement shall be met by providing bona 
fide evidence that a permit or certificate was granted at 
the time of access in accordance with Article 5, para-
graph 1 (d);
The permit or certificate issued at the time of access 
in accordance with Article 5, paragraph 1 (d) and reg-
istered with the ABS Clearing House Mechanism, in 
accordance with Article 5 paragraph 2 shall constitute 
an internationally recognised certificate of compliance.
The internationally recognised certificate of compli-
ance shall serve as evidence that the genetic resource 
in question has been obtained, accessed and used in 
accordance with prior informed consent and that mutu-
ally agreed terms have been entered into, in accordance 
to national legislation on access and benefit-sharing of 
the country providing the genetic resource. Disclosure 
requirements shall be met by providing an internation-
ally recognised certificate or permit. The internation-
ally recognised certificate of compliance shall contain 
the following minimum information:
a) Issuing national authority;
b) Details of the provider;
c) A codified unique alpha numeric identifier where 
feasible;
d) Details of the rights holders of associated traditional 
knowledge, as appropriate;
e) Details of the user;
f) Subject-matter covered by the certificate;
g) Geographic location of the access activity;
h) Link to mutually agreed terms;
i) Uses permitted and restrictions of use;
j) Conditions of transfer to third parties if any;
k) Date of issuance.
The Conference of the Parties serving as the meeting 
of the Parties to this Protocol shall consider additional 
29 SUSTAINABLE DEVELOPMENT LAW & POLICY
modalities of the internationally recognized certificate 
of compliance system, taking into account the need to 
minimize transaction costs and to ensure feasibility, 
practicality and flexibility.56
The certificate can contribute to the monitoring and trace-
ability of genetic resources. It appears to have some degree of 
support, at least regarding an analysis of this proposal to deter-
mine whether it should be included in the Regime and, if so, how 
this should be accomplished. The certificate could be required 
in patent applications to provide evidence of compliance with 
national legislation on ABS, including prior informed consent 
and benefit sharing, thus fulfilling a role in supporting the dis-
closure of origin requirement.
CBD COP Decision VIII/4C established an Expert Group 
(“EG”) on an internationally recognized certificate of origin/
source/legal provenance.57 The Group agreed that the basic role 
of any certificate system would be to provide evidence of com-
pliance with national ABS legislation. This could be achieved 
by a system of national certificates with standard features to 
allow for their international recognition.
The Group58 identified a number of points common for all 
proposals of a certificate, including that it could be required for 
presentation at specific checkpoints in the user countries, inter 
alia patent and in general IP applications.59 Indeed, the certifi-
cate of origin could perhaps be integrated into the existing sys-
tem of requirements for disclosure of information in the patent 
system. A majority of certificate proposals envisage a system 
of checkpoints at which disclosure of the certificate of origin 
would be required for the purposes of processing IP applica-
tions, among other things. Compliance with disclosure require-
ments would be facilitated where an internationally recognized 
certificate could act as evidence of conformance with national 
and international law.60
However, the certificate, depending on its design, may raise 
other international trade issues. Some rules of the trade system 
might apply to it, especially those related to technical barriers 
to trade. In this regard, considering that the certificate could be 
a document attached to the transfers/export (international trade) 
of genetic resources it also should be analyzed in the context 
of the relevant rules of the WTO regarding non discrimination 
(the Most Favored Nation Principle and the National Treatment 
Principle) as well as the appropriate measures contained in the 
Agreement on Technical Barriers to Trade (“TBT”), which 
governs the elaboration and use of technical regulations, stan-
dards, and conformity assessment procedures in a way that do 
not create unnecessary obstacles to international trade. The cer-
tificate could be considered a technical regulation and it must 
take into account the relevant provisions of the TBT Agreement, 
especially article 2.2: technical regulations shall be no more 
restrictive than necessary to fulfill a legitimate objective and 
the requirement that technical measures shall be the less trade 
restrictive in light of applicable risks.61
• Technology transfer as an element of the benefit-sharing 
component of the IR.
Annex I to Decision IX/12, under section III. B. on “Fair 
and equitable benefit-sharing” also includes as a component to 
be further elaborated, the access and transfer of technology. A 
technology transfer measure could be developed in the context 
of the benefit sharing component of the IR.62 The Draft Protocol 
provides (article 18 bis) that:
In accordance with Articles 15, 16 and 19, Parties 
shall collaborate, cooperate and contribute in scientific 
research and development programmes, particularly 
biotechnological research activities, as a means to gen-
erate and share benefits in accordance with Article 4 of 
this Protocol. This shall include measures by developed 
country Parties that provide incentives, to companies 
and institutions within their jurisdiction, to promote 
and encourage access to technology by, and transfer 
of technology to, developing countries, including the 
least developed among them, in order to enable them 
to create a sound and viable technological base. Where 
possible, such collaborative activities shall take place 
in the country providing genetic resources.63
It is outside the scope of this article to analyze the rela-
tionship between IPRs in general, and TRIPS in particular, and 
technology transfer in the context of the CBD. However, it is 
clear that technology transfer is a key element of the ABS CBD 
provisions64 and of the IR. As one study has pointed out “The 
provisions of the Convention on technology transfer reflect the 
consensus of the international community laid down in key inter-
national policy documents, that the development, transfer, adap-
tation and diffusion of technology and the building of capacity is 
crucial for achieving sustainable development.”65 For instance, 
technology transfer could be one element of structuring mutu-
ally agreed terms and benefit sharing arrangements.
At the same time, transfer of technology (e.g. protected by 
IPRs) may create some links between the IR and TRIPS provi-
sions on this matter.66
FACTUAL OVERVIEW OF RELEVANT PROVISIONS/
DEVELOPMENTS/PROCESSES AT UPOV67
The International Convention for the Protection of New 
Varieties of Plants was signed in Paris in 1961 and entered into 
force in 1968. It was revised in 1972, 1978, and 1991. The 1991 
Act of the UPOV Convention entered into force in 1998. The 
purpose of the UPOV Convention is “to ensure that the members 
of the Union acknowledge the achievement of breeders of new 
varieties of plants, by granting to them an intellectual property 
right, on the basis of a set of clearly defined principles.”68 Thus, 
the Convention provides a sui generis form of intellectual pro-
tection specifically adapted to the process of plant breeding and 
developed with the aim of encouraging breeders to develop new 
varieties of plants. To be eligible for protection, varieties have 
to be: (i) distinct from existing, commonly known varieties; 
(ii) sufficiently uniform; (iii) stable; and, (iv) new in the sense 
that they must not have been commercialized prior to certain 
dates established by reference to the date of the application for 
protection.69 The Convention offers protection to the breeder, 
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in the form of a “breeder’s right,” if his plant variety satisfies 
the above conditions. The scope of the breeder’s right is, how-
ever, limited by two important exceptions in Article 15. The 
first exception, known as the “breeder’s exemption” allows the 
use of the propagating material of the protected variety, with-
out prior authorization, for the purpose of breeding other vari-
eties. The breeder’s exemption optimizes variety improvement 
by ensuring that germplasm sources remain accessible to all 
breeders. The second exception concerns the right of farmers to 
use farm-saved seed for replanting. This is known as the “farm-
ers’ privilege” and seeks to safeguard the common practice of 
farmers saving their own seed for the purpose of re-sowing.70 
However, the Convention requires that the farmers’ privilege be 
regulated “within reasonable limits and subject to safeguarding 
of the legitimate interests of the breeder.” As of August 1, 2004, 
55 States were a Party to the UPOV Convention. The mission of 
UPOV is “to provide and promote an effective system of plant 
variety protection, with the aim of encouraging the development 
of new varieties of plants, for the benefit of society.”71
• Relationship to access and benefit-sharing
In response to notifications by the Executive Secretary 
inviting relevant international organizations to contribute to 
the work on access and benefit-sharing, the Vice Secretary-
General of UPOV provided detailed replies highlighting the 
access and benefit-sharing aspects of the UPOV Convention. 
The UPOV submission is included in the compilation of submis-
sions by Parties, international organizations, and other relevant 
stakeholders.72
In these communications, UPOV highlighted the impor-
tance of access to genetic resources to ensure progress in plant 
breeding. It also pointed to the concept of the breeder’s exemp-
tion in the UPOV Convention which reflects the view of UPOV 
that the worldwide community of breeders needs access to all 
forms of breeding material to sustain progress in plant breeding 
and hence maximize the use of genetic resources for the benefit 
of society. The communications also include reference to the 
inherent benefit-sharing principles of the UPOV Convention, 
in the form of breeder’s exemption and other exceptions to the 
breeder’s right. Concern is expressed with respect to any other 
measures for benefit-sharing that could introduce unnecessary 
barriers to progress in breeding and the utilization of genetic 
resources. Finally, UPOV urges the Working Group on Access 
and Benefit-Sharing to recognize these principles in its work and 
to ensure that any measures it develops are supportive of these 
principles and of the UPOV Convention.
UPOV is of the opinion that the Convention on Biologi-
cal Diversity and the UPOV Convention should be mutually 
supportive and the international regime on access to genetic 
resources and benefit-sharing should be designed so that the 
mutual supportiveness of the UPOV Convention and the CBD 
will not be affected. The views of UPOV with respect to the 
work of the Working Group on Access and Benefit-Sharing, 
adopted by the Council of UPOV at its thirty-seventh ordinary 
session on October 23, 2003, were provided to the Secretariat 
prior to the second meeting of the Working Group. These views 
provide a useful overview of issues related to the international 
regime from the perspective of UPOV.73
A further contribution was provided by UPOV in prepara-
tion for the fourth meeting of the Working Group on Access and 
Benefit-Sharing and was made available in a document that high-
lights that the UPOV Convention is not an instrument relating to 
access and benefit-sharing.74 As further detailed in the UPOV 
contribution, it was requested that “consideration is made that 
any measures pursued in the international regime do not under-
mine plant variety protection according to the UPOV Conven-
tion. For its part UPOV supports the view that the Convention 
on Biological Diversity and relevant international instruments 
dealing with intellectual property rights, including the UPOV 
Convention, should be mutually supportive.”75
UPOV has also prepared a study76 on the impact of plant 
variety protection and its report is now available on UPOV’s 
website. The study indicates that “the UPOV system of plant 
variety protection provides an effective incentive for plant 
breeding in many different situations and in various sectors, and 
results in the development of new, improved varieties of benefit 
for farmers, growers and consumers” and that “farmers, grow-
ers and breeders have access to best varieties produced by the 
breeders throughout UPOV member territories.”77
The position of the UPOV Council on access to genetic 
resources and benefit-sharing related to plant breeders’ rights 
(“PBR”) (adopted by the UPOV Council in its thirty-seventh ses-
sion, on October 23, 2003), mentioned above, needs to be briefly 
presented here to fully understand the options and scenarios.
Access to genetic resources: “UPOV considers that plant 
breeding is a fundamental aspect of sustainable use and devel-
opment of genetic resources. It is of the opinion that access to 
genetic resources is a key requirement for sustainable and sub-
stantial progress in plant breeding. The concept of the “breeders’ 
exemption” in the UPOV Convention, whereby acts done for the 
purpose of breeding other varieties are not subject to any restric-
tion, reflects the view of UPOV that the worldwide community 
of breeders needs access to all forms of breeding material to sus-
tain greatest progress in plant breeding, and thereby, to maxi-
mize the use of genetic resources for the benefit of society.”78
Disclosure of origin: “. . . UPOV encourages information 
on the origin of the plant material, used in breeding of the vari-
ety, to be provided where this facilitates the examination [for 
compliance with the conditions of protection], but could not 
accept this as an additional condition of protection since the 
UPOV Convention provides that protection should be granted 
to plant varieties fulfilling the conditions of novelty, distinct-
ness, uniformity, stability and a suitable denomination and does 
not allow any further or different conditions for protection . . . . 
Thus, if a Country decides, in the frame of its overall policy, to 
introduce a mechanism for the disclosure of countries of origin 
or geographical origin of genetic resources, such a mechanism 
should not be introduced in a narrow sense, as a condition for 
plant variety protection. A separate mechanism from the plant 
variety legislation, such as that used for phytosanitary require-
ments, could be applied uniformly to all activities concerning 
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the commercialization of varieties, including, for example, seed 
quality or other marketing related regulations”79
Prior Informed Consent: “. . . UPOV encourages the prin-
ciples of transparency and ethical behaviour in the course of 
conducting breeding activities and, in this regard, the access to 
the genetic material used for the development of a new variety 
should be done respecting the legal framework of the country 
of origin of the genetic material. However, the UPOV Conven-
tion requires that the breeder rights should not be subject to any 
further or different conditions than those required to obtain pro-
tection. UPOV notes that this is consistent with article 15 of the 
CBD, which provides that the determination of access to genetic 
resources rests with the national governments and is subject to 
national legislation. . . .”80
Benefit-sharing: “UPOV would be concerned if any mecha-
nisms to claim the sharing of revenues were to impose an addi-
tional administrative burden on the authority entrusted with the 
grant of breeder’s rights and an additional financial obligation 
on the breeder when varieties are used for further breeding. 
Indeed, such an obligation for benefit sharing would be incom-
patible with the principle of the breeder´s exemption established 
in the UPOV Convention whereby acts done for the purpose of 
breeding other varieties are not, under the UPOV Convention, 
subject to any restriction and the breeders of protected varieties 
(initial varieties) are not entitled to financial benefit sharing of 
varieties developed from the initial varieties, except in the case 
of essentially derived varieties. . . .”81
Access and PBR: The legislation on access to genetic mate-
rial and the legislation dealing with the grant of breeders’ rights 
pursue different objectives, have different scopes of applica-
tion, and require a different administrative structure to monitor 
their implementation. Therefore, it is considered appropriate to 
include them in different legislation, although such legislation 
should be compatible and mutually supportive.82
Later, the UPOV Council, at its twenty-fifth extraordinary 
session held in Geneva on April 11, 2008, decided to request the 
COP IX to include in the IR decisions the following paragraphs: 
“Recognizing that UPOV supports the view that the Convention 
on Biological Resources and the UPOV Convention should be 
mutually supportive” and “Further Instructs the Ad-hoc Open 
Ended Working Group on Access and Benefit Sharing that any 
provisions which it develops for an international regime on 
access and benefit sharing should ensure mutual supportiveness 
with the UPOV Convention.”83
THE RELATIONSHIPS BETWEEN UPOV AND THE IR
UPOV has a direct relevance for the sustainable use of plant 
genetic resources and for the CBD objectives. However, in the 
light of the current IR negotiations, the most relevant issues con-
necting the IR and UPOV are the disclosure of origin/certificate 
and its relationship with UPOV provisions, and the technology 
transfer measures related to Plant Breeders Rights. A potential 
disclosure requirement/check point for the certificate would be 
the plant breeders’ right applications,84 but UPOV is of the opin-
ion that this could not be an additional condition of protection. 
Also TT provisions to be included in the IR could be related to 
Plant Breeders’ Rights.
It does not seem that the current IR components as set forth 
in Annex to Decision IX/12 or in the Draft Protocol could nega-
tively impact the basic principles of UPOV, including the freedom 
to use developed varieties that are protected solely by PVP for 
further breeding without the consent of the breeder (the breeder 
exemption),85 except for the issue of disclosure of origin drafted 
as a condition for protection. However, depending on the form of 
any future amendments or recommendations and resulting obliga-
tions, there may still be the potential to impact UPOV principles.
OPTIONS AND SCENARIOS
THE IR AND THE WTO
There are three relevant aspects of the IR which may have 
an impact on the WTO rules: the disclosure of origin; the cer-
tificate of compliance; and technology transfer. The follow-
ing paragraphs explore the different scenarios and options.86 It 
should be pointed out again that the current text of the Draft 
Protocol is entirely open to further negotiations and nothing of 
its content can be considered agreed.
• Disclosure requirements/certificate of compliance devel-
oped in the CBD IR negotiations and its relationship to the 
WTO provisions.
The inclusion and discussion of disclosure requirements and 
the use of the certificate in patent applications have both been con-
tentious issues during the IR negotiations.87 However, one poten-
tial scenario would be the inclusion of some form of disclosure 
requirement in the IR negotiations. In this regard, it has been sug-
gested that the inclusion of mechanisms such as the disclosure of 
origin of genetic resources and traditional knowledge, or the cer-
tificate in patent or other IPR filing procedures as proposed, would 
strengthen mutual supportiveness between the WTO’s IPR sys-
tem and the CBD ABS IR. Due to the nature of a legally binding 
instrument of the ABS Protocol, the countries should develop—in 
their national legislation—disclosure of origin requirements to 
comply with the international obligations. While there may be 
some variances with regard to the scope, consequences, and prac-
tical operations of these requirements, some experts agree that88 
in general the requirements of disclosure do not run counter to the 
international IP agreements (with regard to the UPOV Conven-
tion, see paragraph 78) and the TRIPS agreement in particular.89 
In addition, there are ongoing negotiations regarding disclosure at 
the WTO and no final decision has been made yet whether or not 
to accept the disclosure requirements in the TRIPS Agreement.
Alternatively, a “soft version” of the disclosure could also be 
developed at the CBD to encourage the adherence of some coun-
tries that are already opposed to disclosure requirement (both in 
the WTO and the CBD).90 However, some delegations and stake-
holders do not support any disclosure requirements in IP appli-
cations, and support alternative mechanisms to address concerns 
regarding misappropriation. In their view, new patent disclosure 
requirements will be ineffective in promoting the objectives 
sought and will introduce uncertainties into the patent system.
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Under this scenario (the development of disclosure require-
ments in the IR), the IR negotiations could promote more clar-
ity on relevant issues, such as the meaning and implications of 
prior informed consent (“PIC”) and benefit-sharing require-
ments. Some of the objections to the disclosure provisions are 
related to the lack of clarity about the exact scope and the legal 
implications of the terms used. A number of terms and concepts 
that are central to the ABS regime, such as “fair and equitable 
benefit sharing,” “traditional knowledge,” and “access to genetic 
resources” are not defined in the CBD. The definition of terms 
is an ongoing process in the CBD and was included in the man-
date of prior ABS Working Group meetings.91 The IR could 
clarify issues of PIC, benefit-sharing, certificate of origin, etc. It 
also could offer guidance on key 
topics, such as the scope of the 
terms “genetic resource” and 
“biological resource.”
This scenario would pres-
ent two main disadvantages: 
the condition of non-CBD 
Party United States, a relevant 
IP country, and difficulties for 
the integration of the disclosure 
requirements into the IP system 
if the provisions would be inte-
grated in the CBD.92
In relation to the certifi-
cate, the IR could provide the 
necessary practical and opera-
tional details for its use in IPR 
applications. The certificate as 
such has not been discussed 
at the WTO, but the develop-
ment of appropriate provisions 
on the certificate under the IR 
could facilitate the use of the 
certificate for disclosure of ori-
gin purposes. It is clear that the certificate has a broader scope 
and objectives than merely serving as an instrument to promote 
disclosure.93 However, a certificate system that serves merely to 
demonstrate compliance with the requirements of the laws of the 
providing country, and a legal title to use of the resources and 
identify the rights and limitations attached to the access and use, 
would not appear to run counter the WTO rules. It would depend 
on how the certificate, if agreed, is finally designed. The certifi-
cate, if it is designed in a non discriminatory fashion, could be 
in harmony with the trade system and both instruments could be 
developed in a mutually supportive manner.
• Disclosure of origin/source at the WTO.
A different scenario is the incorporation of disclosure provi-
sions at the WTO (in this case through a legally binding amend-
ment to the TRIPS Agreement). The exact scope and precise 
content of a potential amendment of the WTO is still uncertain 
(whether or not sanctions for non-compliance will be outside the 
patent law or not; the necessity of proving compliance with PIC 
and benefit-sharing; etc) as well as the amendment per se. This 
scenario would also create mutual supportiveness between the 
IPR system of the WTO and the CBD ABS IR.
In addition, under this scenario the disclosure could con-
tribute to the “defensive protection” 94 of traditional knowledge 
(“TK), therefore supporting the TK component as well as the 
compliance component under the IR. Requirements for dis-
closure of the origin of traditional knowledge associated with 
genetic resources may assist in ensuring prior informed consent 
and equitable benefit-sharing with regard to both traditional 
knowledge and the associated genetic resources.
Considering the large membership of the WTO and its eco-
nomic relevance for the Contracting Parties, this amendment 
would promote a better and wider 
integration of the disclosure of 
origin in the IP system (and in 
the national laws) and would 
promote broad implementation 
of the instrument. In this case, 
the CBD may provide assistance 
and coordination in developing 
and implementing disclosure 
requirements by clarifying terms 
and instruments, including the 
certificate role in the disclosure. 
A reference and description of 
the disclosure mechanism in the 
context Protocol could also be 
established, but the substantive 
provisions would be integrated 
into the TRIPS agreement.
•  No disclosure requirements in 
either instrument.
Another scenario would 
be the absence of disclosure 
requirement provisions in 
both the CBD IR and in the WTO. In this case there will be 
no conflict between the IR and WTO, but, in the view of some 
countries and experts, an opportunity to promote mutual sup-
portiveness between the WTO IPR system and the CBD ABS IR 
could be lost. However, some countries and stakeholders sup-
port this approach because it would avoid the alleged negative 
consequences of new patent disclosure requirements mentioned 
before. These delegations and stakeholders support other mech-
anisms to address concerns regarding misappropriation.
• Technology transfer provisions developed in the IR
Technology transfer provisions could be specifically devel-
oped in the context of the IR benefit sharing component in line with 
the current provisions and language of the CBD itself. This actually 
has been included in the current Draft Protocol (article 18 bis).95
However, considering that the current text is open for nego-
tiations, TT provisions could end up in different forms in the 
final version of the Protocol. The IR could set minimum require-
ments for benefit-sharing to be included in the mutually agreed 
The effective 
implementation of the 
international regime 
will demand input and 
collaboration from a 
range of organizations 
and fora to ensure that  
all cross-sectoral 
issues are given due 
consideration and effect.
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terms, including TT. Technology transfer measures could also 
be developed as a direct obligation for CBD Members. These 
provisions could be similar to the ones already included in the 
CBD (articles 15, 16, and 19).96
Both types of provisions could be drafted to be in harmony 
and provide mutual supportiveness between the IR and the WTO/
TRIPS IPR provisions.97 These measures would be compatible 
and mutually supportive of the WTO efforts and text regarding 
technology transfer, including the Doha Mandate (par. 19).98
THE IR AND UPOV
Despite the UPOV Council position on the IR and the 
UPOV Convention, some authors are of the opinion that a dis-
closure of origin requirement does not necessarily conflict with 
UPOV basic rules.99 At the same time, there are no known ini-
tiatives within UPOV to modify the UPOV Convention for the 
inclusion of disclosure requirements. With regard to the WTO 
discussions on disclosure, these take place in the context of the 
patent system and would not affect PBR protection.100
• Disclosure/certificate requirements established for PBR in 
the IR101
For these reasons, a potential option to include the disclo-
sure of origin in PBR as a result of the CBD IR negotiations 
could conflict with the UPOV interpretation of the compatibility 
between the disclosure requirements and UPOV conditions for 
protection,102 if the disclosure requirements were drafted as an 
additional condition for protection.
Due to the fact that the IR negotiations outcome on disclo-
sure is to be contained in a legally binding instrument, a poten-
tial inconsistency between the two agreements would exist. Such 
an approach could be a disincentive for the UPOV members to 
become Parties to the legally binding IR.
Another option is to amend the UPOV Convention to 
include a disclosure of origin condition for the protection of 
Plant Breeders’ Rights. However, there is no information that 
such a process has been suggested by UPOV members.
• Exclusion of PBR from the disclosure/certificate or an alter-
native drafting
One option is to exclude PBR applications from the dis-
closure provisions or to create a different and special system, 
taking into account both the legal and technical implications of 
such system for the case of plant varieties. A special disclosure 
requirement could be designed taking into account the legal 
requirements and conditions established in the UPOV Conven-
tion and the process of the access and use of plant genetic mate-
rial for the breeding of new varieties.
• Technology transfer provisions and UPOV
There are not specific technology transfer provisions as 
such in the UPOV Convention. However, similar arguments 
and conclusions to the ones presented in the WTO section could 
be made with regard to TT provisions developed in the IR and 
UPOV.103 The IR could establish TT provisions related to plant 
variety protection, which could co-exist in harmony and be 
mutually supportive of the UPOV Convention.
• IR statement on mutual supportiveness with the UPOV 
Convention
UPOV Council statements have called repeatedly for 
mutual supportiveness between both instruments. In addition, 
references to UPOV in the current IR negotiating text are found 
under some of the options for the IR Scope. One possible option 
is to expressly include a reference to the mutual supportiveness 
between the UPOV Convention and the IR. However, it could 
be objected to on the grounds that similar statements could also 
be made for many other international instruments and processes.
CONCLUSION
There is a lot of space to strengthen mutual supportiveness 
between the IR outcome and the WTO, WIPO, and UPOV pro-
cesses and instruments. In principle, the IR Protocol, could co-
exist in harmony with the other treaties or processes, taking into 
account the arguments and options presented in this article.
The calls for mutual supportiveness between the CBD, 
WTO, WIPO, and UPOV regimes can be read as implying the 
need to make compatible multiple regimes with very different 
objectives, approaches, and values demanding and claiming 
legal protection.104
The effective implementation of the international regime 
will demand input and collaboration from a range of organiza-
tions and fora to ensure that all cross-sectoral issues are given 
due consideration and effect.105 Therefore, it is important to fos-
ter closer co-operation and co-ordination between the processes 
of the WTO and UPOV and the Convention IR negotiations in 
order to better capitalize on potential synergies between the pro-
spective international regime on ABS and the IP system.
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